Efficacy of Virtual Reality Based Exercise Regimes on Kinesiophobia, Pain and Functional Disability in Patients With Knee Osteoarthritis

March 20, 2023 updated by: Foundation University Islamabad
Knee Osteoarthritis is one of the most prevalent degenerative conditions in Pakistan. Although a variety of Physical therapy treatments have been proven to be beneficial in patients with early stages of knee Osteoarthritis. However, a few secondary impairments like Kinesiophobia which is the fear of movement have been unaddressed. Usually after conventional physical therapy, patients find immediate or short-term relief and that leads to cessation of follow up sessions. In situations like these, kinesiophobia is the greatest threat to mobility and can eventually effect quality of life by decreasing functional disability.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Rawalpindi, Punjab, Pakistan, 46000
        • Foundation University College of Physical Therapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with unilateral knee OA involving mediolateral compartment
  • Knee OA grade 2
  • Aged 40-65 years
  • Both Male and Female
  • NPRS value greater than

Exclusion Criteria:

  • Patients with history of
  • History of systemic disorder (e.g., rheumatoid arthritis, ankylosing spondylitis).
  • History of malignancy.
  • History of trauma.
  • Previous knee surgery.
  • Congenital musculoskeletal deformity (e.g., scoliosis, kyphosis).
  • Patients with history of fracture
  • Patients with history of Chondropatella Malacia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Conventional Physical Therapy Regime for Knee Osteoarthrithis

Pt will receive conventional therapy targeting stretching and stretching of knee musculature in combination with electrotherapy for pain modulation.

Frequency : 2-3 times for a duration of 6 weeks Pt will be guided home plan based exercises.

Participants of Group A will receive the conventional physical therapy for Knee Osteoarthistis for a duration of 6 weeks atleast 2 times a week
Experimental: Virtual reality Based Therapeutic Exercise Regimes

VR-based therapeutic exercise regimes utilizing Xbox, that focus on different activities like Partial squatting, lunges, side lunge, calf raises, and hamstring curls.

Gaming exercises begin will an easy warm up round and get challenging with different rounds of each game as the patient progresses to week 6.

Frequency: 2-3 times for a duration for 6 weeks Pt will be guided home plan based exercises

  • Participants of Group B will receive Virtual Reality Based therapeutic exercises on the Xbox. The difficulty level of the games will progess each week. The duration of training will also also progress at treatment week progresses.
  • Frequency: 2-3 times a week for 6 weeks. Minimum 12 sessions in total.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Kinesiophobia
Time Frame: 6 weeks
Kinesiophobia will be measured using the Tampa Scale of Kinesiophobia
6 weeks
Pain intensity
Time Frame: 6 weeks
Will be Measured using the Numeric Pain rating scale
6 weeks
Functional Disability
Time Frame: 6 weeks
Will be measured using WOMAC Osteoarthritis Index
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2023

Primary Completion (Anticipated)

June 15, 2023

Study Completion (Anticipated)

July 1, 2023

Study Registration Dates

First Submitted

March 9, 2023

First Submitted That Met QC Criteria

March 20, 2023

First Posted (Actual)

March 21, 2023

Study Record Updates

Last Update Posted (Actual)

March 21, 2023

Last Update Submitted That Met QC Criteria

March 20, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthristis

Clinical Trials on Conventional Physical Therapy for Knee Osteoarthriths

Subscribe